{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:48:37Z","timestamp":1773413317029,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04595-z","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:54:23Z","timestamp":1770634463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating single-cell and spatial transcriptomics with pan-cancer bulk sequencing identifies OSR2 as a multifaceted biomarker for prognosis and tumor immunity"],"prefix":"10.1007","volume":"17","author":[{"given":"Zhihui","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanglin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dechao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"4595_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cancergen.2025.06.004","volume":"296","author":"J John","year":"2025","unstructured":"John J, Bapat A, Gahlaut S, et al. Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast Cancer. Cancer Genet. 2025;296:65\u201375. https:\/\/doi.org\/10.1016\/j.cancergen.2025.06.004.","journal-title":"Cancer Genet"},{"key":"4595_CR2","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2025.0861","author":"A Guijarro","year":"2025","unstructured":"Guijarro A, Allavena G, Pisciotta L, et al. Aging-Related mechanisms underlying carcinogenesis: therapeutic opportunities. Aging Dis. 2025. https:\/\/doi.org\/10.14336\/ad.2025.0861.","journal-title":"Aging Dis"},{"issue":"1","key":"4595_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.21147\/j.issn.1000-9604.2024.01.07","volume":"36","author":"Z Wu","year":"2024","unstructured":"Wu Z, Gu T, Xiong C, et al. Genomic characterization of peritoneal lavage cytology-positive gastric cancer. Chin J Cancer Res. 2024;36(1):66\u201377. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2024.01.07.","journal-title":"Chin J Cancer Res"},{"issue":"5","key":"4595_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1515\/jtim-2024-0019","volume":"12","author":"N Tan","year":"2024","unstructured":"Tan N, Li Y, Ying J, et al. Histological transformation in lung adenocarcinoma: insights of mechanisms and therapeutic windows. J Transl Int Med. 2024;12(5):452\u201365. https:\/\/doi.org\/10.1515\/jtim-2024-0019.","journal-title":"J Transl Int Med"},{"issue":"1","key":"4595_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40779-024-00526-7","volume":"11","author":"D-C Feng","year":"2024","unstructured":"Feng D-C, Zhu W-Z, Wang J, et al. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy. Mil Med Res. 2024;11(1):21. https:\/\/doi.org\/10.1186\/s40779-024-00526-7.","journal-title":"Mil Med Res"},{"issue":"1","key":"4595_CR6","doi-asserted-by":"publisher","first-page":"e21200037","DOI":"10.14440\/bladder.2024.0062","volume":"12","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhang F, Ying Y, et al. The role and clinical potential of RNA modifications in bladder cancer. Bladder. 2025;12(1):e21200037. https:\/\/doi.org\/10.14440\/bladder.2024.0062.","journal-title":"Bladder"},{"issue":"5","key":"4595_CR7","doi-asserted-by":"publisher","first-page":"101065","DOI":"10.1016\/j.jpha.2024.101065","volume":"15","author":"O Menyhart","year":"2025","unstructured":"Menyhart O, Kothalawala WJ, Gy\u0151rffy B. A gene set enrichment analysis for cancer hallmarks. J Pharm Anal. 2025;15(5):101065. https:\/\/doi.org\/10.1016\/j.jpha.2024.101065.","journal-title":"J Pharm Anal"},{"issue":"1","key":"4595_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.wjam.2024.12.004","volume":"35","author":"T-y Gao","year":"2025","unstructured":"Gao T-y, Zhang F-c, Pan R-f, et al. Effects of direct moxibustion on antigen-presenting cells in gastric tissue of rat models with gastric cancer: understanding the immunological mechanisms. World J Acupunct Moxibustion. 2025;35(1):66\u201374. https:\/\/doi.org\/10.1016\/j.wjam.2024.12.004.","journal-title":"World J Acupunct Moxibustion"},{"issue":"3","key":"4595_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.21147\/j.issn.1000-9604.2024.03.03","volume":"36","author":"J Li","year":"2024","unstructured":"Li J, Xu Y, Zang A, et al. Tislelizumab in previously treated, locally advanced unresectable\/metastatic microsatellite instability-high\/mismatch repair-deficient solid tumors. Chin J Cancer Res. 2024;36(3):257\u201369. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2024.03.03.","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"4595_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.56434\/j.arch.esp.urol.20257802.27","volume":"78","author":"J Cao","year":"2025","unstructured":"Cao J. Effect of immune checkpoint inhibitors on advanced prostate cancer: a meta-analysis. Arch Esp Urol. 2025;78(2):194\u2013206. https:\/\/doi.org\/10.56434\/j.arch.esp.urol.20257802.27.","journal-title":"Arch Esp Urol"},{"issue":"2","key":"4595_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ydbio.2006.08.063","volume":"301","author":"JJ Tena","year":"2007","unstructured":"Tena JJ, Neto A, de la Calle-Mustienes E, et al. Odd-skipped genes encode repressors that control kidney development. Dev Biol. 2007;301(2):518\u201331. https:\/\/doi.org\/10.1016\/j.ydbio.2006.08.063.","journal-title":"Dev Biol"},{"issue":"2","key":"4595_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbrc.2010.06.054","volume":"398","author":"S Kawai","year":"2010","unstructured":"Kawai S, Abiko Y, Amano A. Odd-skipped related 2 regulates genes related to proliferation and development. Biochem Biophys Res Commun. 2010;398(2):184\u201390. https:\/\/doi.org\/10.1016\/j.bbrc.2010.06.054.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"4595_CR13","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1177\/0022034517719749","volume":"96","author":"X Fu","year":"2017","unstructured":"Fu X, Xu J, Chaturvedi P, et al. Identification of Osr2 transcriptional target genes in palate development. J Dent Res. 2017;96(12):1451\u20138. https:\/\/doi.org\/10.1177\/0022034517719749.","journal-title":"J Dent Res"},{"issue":"6","key":"4595_CR14","doi-asserted-by":"publisher","first-page":"e27582","DOI":"10.1016\/j.heliyon.2024.e27582","volume":"10","author":"W Yang","year":"2024","unstructured":"Yang W, Liu X, He Z, et al. Odd skipped-related 2 as a novel mark for labeling the proximal convoluted tubule within the zebrafish kidney. Heliyon. 2024;10(6):e27582. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27582.","journal-title":"Heliyon"},{"issue":"8","key":"4595_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.gep.2013.06.007","volume":"13","author":"S Kawai","year":"2013","unstructured":"Kawai S, Michikami I, Kitagaki J, et al. Expression pattern of zinc-finger transcription factor Odd-skipped related 2 in murine development and neonatal stage. Gene Expr Patterns. 2013;13(8):372\u20136. https:\/\/doi.org\/10.1016\/j.gep.2013.06.007.","journal-title":"Gene Expr Patterns"},{"key":"4595_CR16","doi-asserted-by":"publisher","first-page":"5780538","DOI":"10.1155\/2016\/5780538","volume":"2016","author":"WH Li","year":"2016","unstructured":"Li WH, Zhou ZJ, Huang TH, et al. Detection of OSR2, VAV3, and PPFIA3 methylation in the serum of patients with gastric cancer. Dis Markers. 2016;2016:5780538. https:\/\/doi.org\/10.1155\/2016\/5780538.","journal-title":"Dis Markers"},{"issue":"3","key":"4595_CR17","doi-asserted-by":"publisher","first-page":"e0248342","DOI":"10.1371\/journal.pone.0248342","volume":"16","author":"D Uysal","year":"2021","unstructured":"Uysal D, Kowalewski KF, Kriegmair MC, et al. A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer. PLoS One. 2021;16(3):e0248342. https:\/\/doi.org\/10.1371\/journal.pone.0248342.","journal-title":"PLoS One"},{"issue":"13","key":"4595_CR18","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1016\/j.cell.2024.04.023","volume":"187","author":"J Zhang","year":"2024","unstructured":"Zhang J, Li J, Hou Y, et al. Osr2 functions as a biomechanical checkpoint to aggravate CD8(+) T cell exhaustion in tumor. Cell. 2024;187(13):3409-26.e24.","journal-title":"Cell"},{"issue":"1","key":"4595_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40164-022-00337-3","volume":"11","author":"D Feng","year":"2022","unstructured":"Feng D, Zhu W, Shi X, et al. Spindle and kinetochore-associated complex subunit 3 could serve as a prognostic biomarker for prostate cancer. Exp Hematol Oncol. 2022;11(1):76. https:\/\/doi.org\/10.1186\/s40164-022-00337-3.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"4595_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.32604\/or.2024.045050","volume":"32","author":"X Ye","year":"2024","unstructured":"Ye X, Tuo Z, Chen K, et al. Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF). Oncol Res. 2024;32(3):503\u201315. https:\/\/doi.org\/10.32604\/or.2024.045050.","journal-title":"Oncol Res"},{"key":"4595_CR21","doi-asserted-by":"publisher","first-page":"1042118","DOI":"10.3389\/fonc.2022.1042118","volume":"12","author":"W Zhu","year":"2022","unstructured":"Zhu W, Feng D, Shi X, et al. A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer. Front Oncol. 2022;12:1042118. https:\/\/doi.org\/10.3389\/fonc.2022.1042118.","journal-title":"Front Oncol"},{"issue":"3","key":"4595_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00432-024-05640-6","volume":"150","author":"R Wu","year":"2024","unstructured":"Wu R, Li D, Zhang S, et al. A pan-cancer analysis of the oncogenic and immunological roles of transglutaminase 1 (TGM1) in human cancer. J Cancer Res Clin Oncol. 2024;150(3):123. https:\/\/doi.org\/10.1007\/s00432-024-05640-6.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4595_CR23","doi-asserted-by":"publisher","DOI":"10.1200\/po.17.00073","author":"R Bonneville","year":"2017","unstructured":"Bonneville R, Krook MA, Kautto EA, et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017. https:\/\/doi.org\/10.1200\/po.17.00073.","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"4595_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, et al. The immune landscape of cancer. Immunity. 2018;48(4):812-30.e14.","journal-title":"Immunity"},{"issue":"2","key":"4595_CR25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338-54.e15.","journal-title":"Cell"},{"issue":"7283","key":"4595_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463(7283):899\u2013905. https:\/\/doi.org\/10.1038\/nature08822.","journal-title":"Nature"},{"key":"4595_CR27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26476","author":"J Racle","year":"2017","unstructured":"Racle J, de Jonge K, Baumgaertner P, et al. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017. https:\/\/doi.org\/10.7554\/eLife.26476.","journal-title":"Elife"},{"issue":"21","key":"4595_CR28","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu CJ, Hu FF, Xia MX, et al. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/bty411.","journal-title":"Bioinformatics"},{"key":"4595_CR29","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2025.0916","author":"CY Guo","year":"2025","unstructured":"Guo CY, Du YF, Yan HC, et al. The clinical relevance of FTO as a demethylase beyond cancer: molecular mechanisms and therapeutic opportunities. Aging Dis. 2025. https:\/\/doi.org\/10.14336\/ad.2025.0916.","journal-title":"Aging Dis"},{"key":"4595_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkae075","author":"F Shao","year":"2025","unstructured":"Shao F, Wang Z, Ye L, et al. Basic helix-loop-helix ARNT like 1 regulates the function of immune cells and participates in the development of immune-related diseases. Burns Trauma. 2025;13:tkae075. https:\/\/doi.org\/10.1093\/burnst\/tkae075.","journal-title":"Burns Trauma"},{"key":"4595_CR31","doi-asserted-by":"publisher","DOI":"10.14440\/bladder.2024.0071","author":"M Hegazi","year":"2025","unstructured":"Hegazi M, Pasqualini F, Chiriva-Internati M, et al. SPEF1 and SPEF2 as potential biomarkers in bladder cancer: insights from a comprehensive bioinformatic analysis. Bladder (San Franc). 2025;12(2):e21200039. https:\/\/doi.org\/10.14440\/bladder.2024.0071.","journal-title":"Bladder (San Franc)"},{"issue":"2","key":"4595_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/mdr2.70022","volume":"1","author":"J Li","year":"2025","unstructured":"Li J, Peng J, Wang J, et al. The dual role of exosomes in the tumor microenvironment: from pro-tumorigenic signaling to immune modulation. Med Res. 2025;1(2):257\u201384. https:\/\/doi.org\/10.1002\/mdr2.70022.","journal-title":"Med Res"},{"key":"4595_CR33","doi-asserted-by":"publisher","DOI":"10.34133\/research.0950","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Zhang K, Wu W, et al. POSTN(+) CAF-derived migrasomes drive hepatocellular carcinoma progression and confer resistance to immunotherapy. Res. 2025;8:0950. https:\/\/doi.org\/10.34133\/research.0950.","journal-title":"Res"},{"key":"4595_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/exp.20210263","author":"C Feng","year":"2023","unstructured":"Feng C, Tan P, Nie G, et al. Biomimetic and bioinspired nano-platforms for cancer vaccine development. Exploration. 2023;3(3):20210263. https:\/\/doi.org\/10.1002\/exp.20210263.","journal-title":"Exploration"},{"key":"4595_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/exp.20230134","author":"Y Luo","year":"2024","unstructured":"Luo Y, He X, Du Q, et al. Metal-based smart nanosystems in cancer immunotherapy. Exploration. 2024;4(6):20230134. https:\/\/doi.org\/10.1002\/exp.20230134.","journal-title":"Exploration"},{"issue":"8","key":"4595_CR36","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1111\/jcmm.16317","volume":"25","author":"A Chimento","year":"2021","unstructured":"Chimento A, De Luca A, Nocito MC, et al. SIRT1 is involved in adrenocortical cancer growth and motility. J Cell Mol Med. 2021;25(8):3856\u201369. https:\/\/doi.org\/10.1111\/jcmm.16317.","journal-title":"J Cell Mol Med"},{"key":"4595_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030391","author":"MR de Matos","year":"2019","unstructured":"de Matos MR, Posa I, Carvalho FS, et al. A systematic pan-cancer analysis of genetic heterogeneity reveals associations with epigenetic modifiers. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11030391.","journal-title":"Cancers (Basel)"},{"key":"4595_CR38","doi-asserted-by":"publisher","DOI":"10.34133\/research.0999","author":"J Chen","year":"2025","unstructured":"Chen J, Li X, Chen Q, et al. A DNA nanomachine modulates the stemness-associated signaling pathways for overcoming chemoresistance by temporally programming drug release. Res. 2025;8:0999. https:\/\/doi.org\/10.34133\/research.0999.","journal-title":"Res"},{"issue":"5","key":"4595_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.15252\/emmm.201506055","volume":"8","author":"S Diederichs","year":"2016","unstructured":"Diederichs S, Bartsch L, Berkmann JC, et al. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations. EMBO Mol Med. 2016;8(5):442\u201357. https:\/\/doi.org\/10.15252\/emmm.201506055.","journal-title":"EMBO Mol Med"},{"key":"4595_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95287-x","author":"S Mizuno","year":"2021","unstructured":"Mizuno S, Yamaguchi R, Hasegawa T, et al. Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories. Sci Rep. 2021;11(1):15713. https:\/\/doi.org\/10.1038\/s41598-021-95287-x.","journal-title":"Sci Rep"},{"issue":"1","key":"4595_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"issue":"6","key":"4595_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20(6):303\u201322. https:\/\/doi.org\/10.1038\/s41568-020-0253-2.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4595_CR43","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41556-019-0319-0","volume":"21","author":"S Delaunay","year":"2019","unstructured":"Delaunay S, Frye M. RNA modifications regulating cell fate in cancer. Nat Cell Biol. 2019;21(5):552\u20139. https:\/\/doi.org\/10.1038\/s41556-019-0319-0.","journal-title":"Nat Cell Biol"},{"key":"4595_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70042","author":"H Wu","year":"2025","unstructured":"Wu H, Chen S, Li X, et al. RNA modifications in cancer. MedComm. 2025;6(1):e70042. https:\/\/doi.org\/10.1002\/mco2.70042.","journal-title":"MedComm"},{"issue":"2","key":"4595_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41416-023-02275-1","volume":"129","author":"Q Tang","year":"2023","unstructured":"Tang Q, Li L, Wang Y, et al. RNA modifications in cancer. Br J Cancer. 2023;129(2):204\u201321. https:\/\/doi.org\/10.1038\/s41416-023-02275-1.","journal-title":"Br J Cancer"},{"key":"4595_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.644620","author":"R Li","year":"2021","unstructured":"Li R, Yin YH, Ji XL, et al. Pan-cancer prognostic, immunity, stemness, and anticancer drug sensitivity characterization of N6-methyladenosine RNA modification regulators in human cancers. Front Mol Biosci. 2021;8:644620. https:\/\/doi.org\/10.3389\/fmolb.2021.644620.","journal-title":"Front Mol Biosci"},{"key":"4595_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102211","author":"B Zhang","year":"2024","unstructured":"Zhang B, Hao Y, Liu H, et al. Interplay of RNA m(6)A modification-related geneset in pan-cancer. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12102211.","journal-title":"Biomedicines"},{"issue":"1","key":"4595_CR48","doi-asserted-by":"publisher","first-page":"122","DOI":"10.7150\/jca.101046","volume":"16","author":"H Yuan","year":"2025","unstructured":"Yuan H, Zhu X, Zhang J, et al. Pan-cancer analyses reveal cancer-type-specific autophagy signatures with potential implications for prognosis and therapy response. J Cancer. 2025;16(1):122\u201334. https:\/\/doi.org\/10.7150\/jca.101046.","journal-title":"J Cancer"},{"issue":"32","key":"4595_CR49","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.1038\/s41388-020-1367-4","volume":"39","author":"A Lundberg","year":"2020","unstructured":"Lundberg A, Lindstr\u00f6m LS, Parker JS, et al. A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels. Oncogene. 2020;39(32):5430\u201340. https:\/\/doi.org\/10.1038\/s41388-020-1367-4.","journal-title":"Oncogene"},{"key":"4595_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.06.003","volume":"224","author":"AG Xue","year":"2020","unstructured":"Xue AG, Chan M, Gujral TS. Pan-cancer analysis of the developmental pathways reveals non-canonical wnt signaling as a driver of mesenchymal-type tumors. Transl Res. 2020;224:1\u201315. https:\/\/doi.org\/10.1016\/j.trsl.2020.06.003.","journal-title":"Transl Res"},{"issue":"3","key":"4595_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1158\/1078-0432.Ccr-15-0876","volume":"22","author":"MP Mak","year":"2016","unstructured":"Mak MP, Tong P, Diao L, et al. A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition. Clin Cancer Res. 2016;22(3):609\u201320. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-0876.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4595_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2478\/jtim-2024-0003","volume":"12","author":"B Wang","year":"2024","unstructured":"Wang B, Hao X, Yan J, et al. A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma. J Transl Int Med. 2024;12(3):225\u201343. https:\/\/doi.org\/10.2478\/jtim-2024-0003.","journal-title":"J Transl Int Med"},{"issue":"3","key":"4595_CR53","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1515\/mr-2025-0003","volume":"5","author":"H Fang","year":"2025","unstructured":"Fang H, Liu Y, Wang G, et al. From tumor immunity to precision medicine: the next step in B7-H3\/CD276 research. Med Rev (2021). 2025;5(3):260\u20134. https:\/\/doi.org\/10.1515\/mr-2025-0003.","journal-title":"Med Rev (2021)"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04595-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04595-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04595-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:29:36Z","timestamp":1773397776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04595-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4595"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04595-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using publicly available data from the public databases. All data used in this study were de-identified and previously published. Therefore, no additional ethical approval was required.\u00a0Not applicable. This study did not involve direct participation of human subjects, and all data were obtained from publicly accessible datasets.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"416"}}